LAS VEGAS – ADHD is a common mental disorder among children and teenagers, but many adults also struggle with it. However, the continued shortage of Adderall medication to treat ADHD has left many Nevada patients confused and uncertain about when the shortage will be resolved.

Dr. Ann Childress, who specializes in ADHD treatment at The Center for Psychiatry and Behavioral Medicine and is the President of the American Professional Society of ADHD and related disorders, has been fielding calls from concerned clients due to the shortage.

The shortage was first announced by the FDA in October of 2022, partly due to supply chain issues and manufacturing delays. But now, it is being driven by a rise in consumer demand and a change in access. Due to the pandemic, providers were allowed to prescribe the drug after online consultations, resulting in a surge of prescriptions from 35 million to 41 million a year.

Dr. Childress suggests that patients can check the FDA drug shortages app to see who makes Adderall, the different strengths, and whether it’s available or not. Half the companies say not available, some say end of June. She also recommends being proactive and talking to your doctor, looking at new medications, and checking out “Good RX” for cheaper generic alternatives.

The shortage has caused some patients to experience difficulty in obtaining their medication. “I’ve had to send someone to three different pharmacies to get medication,” said Dr. Childress. For some adults, the shortage has led to work and driving difficulties due to the effects of untreated ADHD.

The issue of the Adderall shortage is ongoing, and Dr. Childress advises patients to stay informed and seek alternatives to ensure they continue to receive the treatment they need.

Credits: 8 News Now

Copyright 2022 702 Times, NV Globe. All rights reserved.